7 WA Centre for Rural Health, University of Western Australia, Perth, Australia Correspondence to Karice K Hyun, The George Institute for Global Health, Sydney Medical School, University of Sydney, ...

Background Effective decongestion is a key therapeutic goal during hospitalisation for acute heart failure (HF), but the ...

For more than two decades, the crucial dilemma of dual antiplatelet therapy (DAPT) after percutaneous coronary intervention (PCI) has remained unchanged: the same therapies used to treat myocardial ...

Background The impact of COVID-19 in hypertrophic cardiomyopathy (HCM), particularly in the post-vaccine era, remains ...

Background Pericarditis may be associated with significant morbidity and mortality and can be a clinically challenging entity ...

Pericarditis remains a clinical diagnosis. No single symptom, biomarker, electrocardiographic pattern or imaging finding is sufficiently sensitive and specific across the full spectrum of disease. The ...

Background Obesity is a major contributor to cardiovascular disease (CVD). Different fat depots may have distinct effects on ...

In the early 2000s, the natural history of heart failure (HF) was vividly illustrated, highlighting a defining feature of HF progression: a prolonged course of fluctuating yet steadily worsening ...

Background Hypochloraemia has emerged as a prognostic marker in heart failure, although the mechanisms underlying chloride ...

Objective The Medical ANtiarrhythmic Treatment or Radiofrequency Ablation in Paroxysmal Atrial Fibrillation (MANTRA-PAF) trial compared radiofrequency catheter ablation (RFA) with antiarrhythmic drug ...

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be ...

Objectives: To quantify the incidence of major adverse events (AEs) occurring in hospital or within 30 days after surgery in patients undergoing coronary artery bypass graft (CABG) surgery and to ...